Freshpet (FRPT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most ...

Rapt Therapeutics (RAPT) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one ...

Zacks All-Cap Core Fund earns an Average Process Pillar rating. The predominant contributor to the rating is the fund's excellent long-term risk-adjusted performance. This can be seen in its ten ...

Investment analysts at Zacks Research reduced their Q1 2025 earnings per share estimates for shares of Onsemi in a note ...

Research analysts at Zacks Research increased their Q1 2025 earnings per share estimates for The PNC Financial Services Group ...

A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts ...

Zacks Dividend Fund earns an Average Process Pillar rating. The main driver of the rating is the firm's retention rate of the firm's portfolio managers, which is 100% over the timeframe for which ...

A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts ...

An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change. The sole determinant of the Zacks rating is a company's ...